Bill Commons

CA AB 260

enacted

Sexual and reproductive health care.

California · 2025-2026 Regular Session · lower

Quick answers

Did CA AB 260 pass?

Yes. CA AB 260 has been enacted into law as of 2025-09-26. Latest recorded action (2025-09-26): Chaptered by Secretary of State - Chapter 136, Statutes of 2025.

What is CA AB 260 about?

(1) The California Constitution provides for the fundamental rights of privacy and to choose to have an abortion. Existing law, the Reproductive Privacy Act, prohibits the state from denying or interfering with a pregnant person's right to choose or obtain an abortion before the viability of the fetus, or when the abortion is necessary to protect the life or health of the pregnant person. Existing law prohibits conditions or restrictions from being imposed on abortion access for incarcerated persons and committed juveniles. Existing laws requiring parental consent for abortion and making assisting in or advertising abortion a crime have been held to be unconstitutional. This bill would repeal those unconstitutional provisions and delete obsolete references to criminal abortion penalties. The bill would make technical changes to provisions authorizing abortion for incarcerated and committed persons. (2) Existing law, the Sherman Food, Drug, and Cosmetic Law, provides for labeling requirements of drugs and devices. The Pharmacy Law requires a pharmacist to dispense a prescription in a container that is correctly labeled with specified information, including the name of the prescriber and the name address of the pharmacy. A violation of the Pharmacy Law is a misdemeanor. This bill would authorize the State Department of Public Health to adopt regulations to include or exclude mifepristone and other medication abortion drugs from the requirements of the Sherman Food, Drug, and Cosmetic Law, but would exclude the drugs from those requirements if the drugs are no longer approved by the United States Food and Drug Administration (FDA) , as specified. The bill would authorize a pharmacist to dispense mifepristone or other drug used for medication abortion without the name of the patient, the name of the prescriber, or the name and address of the pharmacy, subject to specified requirements. The bill would require the pharmacist to maintain a log, as specified, that is not open to inspection by law enforcement without a subpoena, and would prohibit the disclosure of the information to an individual or entity from another state. The bill would prohibit criminal, civil, professional discipline, or licensing action against a pharmacist for manufacturing, transporting, or engaging in specified other acts relating to mifepristone or other medication abortion drugs, and would prohibit the California State Board of Pharmacy from denying an application for licensure or taking disciplinary action against an applicant or licensee for engaging in certain acts relating to mifepristone or other medical abortion drugs. By expanding the scope of a crime under the Pharmacy Law, the bill would impose a state-mandated local program. (3) Existing law establishes various healing arts boards in the Department of Consumer Affairs that license and regulate various healing arts licensees. This bill would prohibit subjecting a healing arts practitioner who is authorized to prescribe, furnish, order, or administer dangerous drugs to civil, criminal, disciplinary, or other administrative action for prescribing, furnishing, ordering, or administering mifepristone or other medication abortion drugs for a use that is different from the use for which that drug has been approved for marketing by the FDA or that varies from an approved risk evaluation and mitigation strategy under federal law, as specified. The bill would state that the laws of another state or federal actions that interfere with the authority of a healing arts practitioner to take specified actions relating to mifepristone or other medication abortion drugs are against the public policy of this state. The bill would prohibit criminal, civil, professional discipline, or licensing actions against an applicant or licensee for manufacturing, transporting, or engaging in certain other acts relating to mifepristone or other medication abortion drugs. (4) Existing law provides for the licensure and regulation of clinics and health facilities by the State Department of Public Health. This bill would prohibit criminal, civil, professional discipline, or licensing action against a licensed clinic or health facility for transporting or engaging in certain other acts relating to mifepristone or other medication abortion drugs that are lawful in California. The bill would prohibit the department from denying an application for licensure or taking disciplinary action against an applicant or licensee for engaging in certain acts relating to mifepristone or other medical abortion drugs. (5) Existing law prohibits a health care provider from knowingly disclosing, transmitting, transferring, sharing or granting access to identifiable medical information related to an individual seeking, obtaining, providing, supporting, or aiding in the performance of an abortion that is lawful under the laws of this state, as specified and subject to specified exclusions. Existing law exempts a health care provider from liability for damages or from civil or enforcement actions for failing to comply this prohibition before January 31, 2026, if the health care provider is working diligently and in good faith to comply with the prohibition. This bill would exempt a health care provider from liability for damages or from civil or enforcement actions for an additional year, until January 31, 2027. (6) Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of disability and health insurers by the Department of Insurance. Existing law prohibits a health care service plan contract or a group or individual disability insurance policy or certificate that covers prescription drugs from limiting or excluding coverage of a drug on the basis that the drug is prescribed for a use that is different from the use for which that drug has been approved for marketing by the FDA. Existing law prohibits a contract between a health care service plan or health insurer and a health care services provider from containing any term that would result in termination or nonrenewal of the contract or otherwise penalize the provider based on a civil judgment, criminal conviction, or another professional disciplinary action in another state if the judgment, conviction, or professional disciplinary action is solely based on the application of another state's law that interferes with a person's right to receive care that would be lawful if provided in California. Existing law also prohibits a health care service plan or health insurer from discriminating against a licensed provider solely on the basis of a civil judgment, criminal conviction, or another professional disciplinary action in another state if the judgment, conviction, or professional disciplinary action is solely based on the application of another state's law that interferes with a person's right to receive care that would be lawful if provided in California. This bill would prohibit a health care service plan contract or a group or individual health insurance policy or certificate that covers prescription drugs from limiting or excluding coverage for brand name or generic mifepristone solely on the basis that the drug is prescribed for a use that is different from the use for which that drug has been approved for marketing by the FDA or that varies from an approved risk evaluation and mitigation strategy, except if the state deems it necessary to address an imminent health or safety concern. The bill would require those contracts and policies to include coverage for brand name or generic mifepristone, even if it has not been approved by the FDA if specified requirements are met, except if the state deems it necessary to address an imminent health or safety concern. The bill would prohibit a plan or insurer from contracting with a health care services provider to terminate or nonrenew the contract or otherwise penalize the provider, or from discriminating against a licensed provider, for manufacturing, transporting, or engaging in certain other acts relating to mifepristone or other medication abortion drugs that are lawful in California. Because a violation of these provisions by a health care service plan would be a crime, the bill would impose a state-mandated local program. (7) This bill would incorporate additional changes to Section 4076 of the Business and Professions Code proposed by AB 1503 to be operative only if this bill and AB 1503 are enacted and this bill is enacted last. (8) The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason. (9) This bill would declare that it is to take effect immediately as an urgency statute.

Who sponsors CA AB 260?

Aguiar-Curry is the primary sponsor of CA AB 260, joined by 19 cosponsors.

Description

(1) The California Constitution provides for the fundamental rights of privacy and to choose to have an abortion. Existing law, the Reproductive Privacy Act, prohibits the state from denying or interfering with a pregnant person's right to choose or obtain an abortion before the viability of the fetus, or when the abortion is necessary to protect the life or health of the pregnant person. Existing law prohibits conditions or restrictions from being imposed on abortion access for incarcerated persons and committed juveniles. Existing laws requiring parental consent for abortion and making assisting in or advertising abortion a crime have been held to be unconstitutional. This bill would repeal those unconstitutional provisions and delete obsolete references to criminal abortion penalties. The bill would make technical changes to provisions authorizing abortion for incarcerated and committed persons. (2) Existing law, the Sherman Food, Drug, and Cosmetic Law, provides for labeling requirements of drugs and devices. The Pharmacy Law requires a pharmacist to dispense a prescription in a container that is correctly labeled with specified information, including the name of the prescriber and the name address of the pharmacy. A violation of the Pharmacy Law is a misdemeanor. This bill would authorize the State Department of Public Health to adopt regulations to include or exclude mifepristone and other medication abortion drugs from the requirements of the Sherman Food, Drug, and Cosmetic Law, but would exclude the drugs from those requirements if the drugs are no longer approved by the United States Food and Drug Administration (FDA) , as specified. The bill would authorize a pharmacist to dispense mifepristone or other drug used for medication abortion without the name of the patient, the name of the prescriber, or the name and address of the pharmacy, subject to specified requirements. The bill would require the pharmacist to maintain a log, as specified, that is not open to inspection by law enforcement without a subpoena, and would prohibit the disclosure of the information to an individual or entity from another state. The bill would prohibit criminal, civil, professional discipline, or licensing action against a pharmacist for manufacturing, transporting, or engaging in specified other acts relating to mifepristone or other medication abortion drugs, and would prohibit the California State Board of Pharmacy from denying an application for licensure or taking disciplinary action against an applicant or licensee for engaging in certain acts relating to mifepristone or other medical abortion drugs. By expanding the scope of a crime under the Pharmacy Law, the bill would impose a state-mandated local program. (3) Existing law establishes various healing arts boards in the Department of Consumer Affairs that license and regulate various healing arts licensees. This bill would prohibit subjecting a healing arts practitioner who is authorized to prescribe, furnish, order, or administer dangerous drugs to civil, criminal, disciplinary, or other administrative action for prescribing, furnishing, ordering, or administering mifepristone or other medication abortion drugs for a use that is different from the use for which that drug has been approved for marketing by the FDA or that varies from an approved risk evaluation and mitigation strategy under federal law, as specified. The bill would state that the laws of another state or federal actions that interfere with the authority of a healing arts practitioner to take specified actions relating to mifepristone or other medication abortion drugs are against the public policy of this state. The bill would prohibit criminal, civil, professional discipline, or licensing actions against an applicant or licensee for manufacturing, transporting, or engaging in certain other acts relating to mifepristone or other medication abortion drugs. (4) Existing law provides for the licensure and regulation of clinics and health facilities by the State Department of Public Health. This bill would prohibit criminal, civil, professional discipline, or licensing action against a licensed clinic or health facility for transporting or engaging in certain other acts relating to mifepristone or other medication abortion drugs that are lawful in California. The bill would prohibit the department from denying an application for licensure or taking disciplinary action against an applicant or licensee for engaging in certain acts relating to mifepristone or other medical abortion drugs. (5) Existing law prohibits a health care provider from knowingly disclosing, transmitting, transferring, sharing or granting access to identifiable medical information related to an individual seeking, obtaining, providing, supporting, or aiding in the performance of an abortion that is lawful under the laws of this state, as specified and subject to specified exclusions. Existing law exempts a health care provider from liability for damages or from civil or enforcement actions for failing to comply this prohibition before January 31, 2026, if the health care provider is working diligently and in good faith to comply with the prohibition. This bill would exempt a health care provider from liability for damages or from civil or enforcement actions for an additional year, until January 31, 2027. (6) Existing law, the Knox-Keene Health Care Service Plan Act of 1975, provides for the licensure and regulation of health care service plans by the Department of Managed Health Care, and makes a willful violation of the act a crime. Existing law provides for the regulation of disability and health insurers by the Department of Insurance. Existing law prohibits a health care service plan contract or a group or individual disability insurance policy or certificate that covers prescription drugs from limiting or excluding coverage of a drug on the basis that the drug is prescribed for a use that is different from the use for which that drug has been approved for marketing by the FDA. Existing law prohibits a contract between a health care service plan or health insurer and a health care services provider from containing any term that would result in termination or nonrenewal of the contract or otherwise penalize the provider based on a civil judgment, criminal conviction, or another professional disciplinary action in another state if the judgment, conviction, or professional disciplinary action is solely based on the application of another state's law that interferes with a person's right to receive care that would be lawful if provided in California. Existing law also prohibits a health care service plan or health insurer from discriminating against a licensed provider solely on the basis of a civil judgment, criminal conviction, or another professional disciplinary action in another state if the judgment, conviction, or professional disciplinary action is solely based on the application of another state's law that interferes with a person's right to receive care that would be lawful if provided in California. This bill would prohibit a health care service plan contract or a group or individual health insurance policy or certificate that covers prescription drugs from limiting or excluding coverage for brand name or generic mifepristone solely on the basis that the drug is prescribed for a use that is different from the use for which that drug has been approved for marketing by the FDA or that varies from an approved risk evaluation and mitigation strategy, except if the state deems it necessary to address an imminent health or safety concern. The bill would require those contracts and policies to include coverage for brand name or generic mifepristone, even if it has not been approved by the FDA if specified requirements are met, except if the state deems it necessary to address an imminent health or safety concern. The bill would prohibit a plan or insurer from contracting with a health care services provider to terminate or nonrenew the contract or otherwise penalize the provider, or from discriminating against a licensed provider, for manufacturing, transporting, or engaging in certain other acts relating to mifepristone or other medication abortion drugs that are lawful in California. Because a violation of these provisions by a health care service plan would be a crime, the bill would impose a state-mandated local program. (7) This bill would incorporate additional changes to Section 4076 of the Business and Professions Code proposed by AB 1503 to be operative only if this bill and AB 1503 are enacted and this bill is enacted last. (8) The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement. This bill would provide that no reimbursement is required by this act for a specified reason. (9) This bill would declare that it is to take effect immediately as an urgency statute.

Introduced
2025-03-17
Latest action
2025-09-26 — Chaptered by Secretary of State - Chapter 136, Statutes of 2025.
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Aguiar-Curryauthor
  • Patelprincipal coauthor
  • Ávila Faríascoauthor
  • Bauer-Kahancoauthor
  • Bermancoauthor
  • Calozacoauthor
  • Garciacoauthor
  • Krellcoauthor
  • Ortegacoauthor
  • Papancoauthor
  • Pellerincoauthor
  • Petrie-Norriscoauthor
  • Quirk-Silvacoauthor
  • Stefanicoauthor
  • Cervantescoauthor
  • Gonzalezcoauthor
  • Limóncoauthor
  • Rubiocoauthor
  • Wahabcoauthor
  • Weber Piersoncoauthor

Committees

Not provided by source.

Action timeline

  1. 2025-01-16

    Read first time. To print.

    reading-1

  2. 2025-01-17

    From printer. May be heard in committee February 16.

  3. 2025-03-17

    Referred to Coms. on HEALTH and B. & P.

    referral-committee

  4. 2025-03-17

    From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended.

    amendment-introduction,amendment-passage,committee-passage,reading-1,reading-2,referral-committee

  5. 2025-03-18

    Re-referred to Com. on HEALTH.

    referral-committee

  6. 2025-04-09

    Coauthors revised.

  7. 2025-04-09

    From committee: Do pass and re-refer to Com. on B. & P. (Ayes 12. Noes 1.) (April 8). Re-referred to Com. on B. & P.

    committee-passage,committee-passage-favorable,referral-committee

  8. 2025-04-29

    From committee: Do pass and re-refer to Com. on APPR. (Ayes 14. Noes 1.) (April 29). Re-referred to Com. on APPR.

    committee-passage,committee-passage-favorable,referral-committee

  9. 2025-04-29

    Coauthors revised.

  10. 2025-05-14

    From committee: Do pass. (Ayes 11. Noes 4.) (May 14).

    committee-passage,committee-passage-favorable

  11. 2025-05-15

    Read second time. Ordered to third reading.

    reading-1,reading-2,reading-3

  12. 2025-05-19

    Read third time. Passed. Ordered to the Senate. (Ayes 61. Noes 11. Page 1601.)

    passage,reading-1,reading-3

  13. 2025-05-20

    In Senate. Read first time. To Com. on RLS. for assignment.

    reading-1,referral-committee

  14. 2025-05-28

    Referred to Coms. on HEALTH and B. P. & E.D.

    referral-committee

  15. 2025-06-02

    From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH.

    amendment-introduction,amendment-passage,committee-passage,reading-1,reading-2,referral-committee

  16. 2025-06-12

    From committee: Amend, and do pass as amended and re-refer to Com. on B. P. & E.D. (Ayes 6. Noes 1.) (June 11).

    amendment-introduction,amendment-passage,committee-passage,referral-committee

  17. 2025-06-13

    Read second time and amended. Re-referred to Com. on B. P. & E.D.

    amendment-passage,reading-1,reading-2,referral-committee

  18. 2025-06-18

    From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on B. P. & E.D.

    amendment-introduction,amendment-passage,committee-passage,reading-1,reading-2,referral-committee

  19. 2025-06-23

    From committee: Do pass and re-refer to Com. on APPR. (Ayes 8. Noes 2.) (June 23). Re-referred to Com. on APPR.

    committee-passage,committee-passage-favorable,referral-committee

  20. 2025-07-07

    In committee: Referred to APPR. suspense file.

    referral-committee

  21. 2025-08-29

    From committee: Do pass. (Ayes 5. Noes 2.) (August 29).

    committee-passage,committee-passage-favorable

  22. 2025-08-29

    Read second time. Ordered to third reading.

    reading-1,reading-2,reading-3

  23. 2025-09-05

    Read third time and amended. Ordered to second reading.

    amendment-passage,reading-1,reading-2,reading-3

  24. 2025-09-08

    Read second time. Ordered to third reading.

    reading-1,reading-2,reading-3

  25. 2025-09-09

    Read third time. Urgency clause adopted. Passed. Ordered to the Assembly. (Ayes 30. Noes 8. Page 2736.).

    amendment-passage,passage,reading-1,reading-3

  26. 2025-09-09

    In Assembly. Concurrence in Senate amendments pending.

  27. 2025-09-10

    Urgency clause adopted. Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 61. Noes 12. Page 3193.).

    amendment-passage,committee-passage,committee-passage-favorable,passage

  28. 2025-09-22

    Enrolled and presented to the Governor at 3 p.m.

    executive-receipt

  29. 2025-09-26

    Approved by the Governor.

    executive-signature

  30. 2025-09-26

    Chaptered by Secretary of State - Chapter 136, Statutes of 2025.

    became-law

Versions

  • 01/16/25 - Introduced — 2025-01-16Compare
  • 03/17/25 - Amended Assembly — 2025-03-17Compare
  • 06/02/25 - Amended Senate — 2025-06-02Compare
  • 06/13/25 - Amended Senate — 2025-06-13Compare
  • 06/18/25 - Amended Senate — 2025-06-18Compare
  • 09/05/25 - Amended Senate — 2025-09-05Compare
  • 09/12/25 - Enrolled — 2025-09-12Compare
  • 09/26/25 - Chaptered — 2025-09-26Compare
  • AB260Compare
  • (document, no version)Compare

Documents

Votes

  • Do pass and be re-referred to the Committee on [Business and Professions]

    2025-04-08 · pass · 12-1

    Member-level votes (15)
    • Sharp-Collins: yes
    • Krell: yes
    • Mark González: yes
    • Carrillo: yes
    • Arambula: yes
    • Patel: yes
    • Schiavo: yes
    • Stefani: yes
    • Celeste Rodriguez: yes
    • Aguiar-Curry: yes
    • Addis: yes
    • Bonta: yes
    • Sanchez: no
    • Flora: other
    • Chen: other

  • Do pass and be re-referred to the Committee on [Appropriations]

    2025-04-29 · pass · 14-1

    Member-level votes (18)
    • Caloza: yes
    • Bains: yes
    • Elhawary: yes
    • Jackson: yes
    • Krell: yes
    • Ahrens: yes
    • Nguyen: yes
    • Bauer-Kahan: yes
    • Wilson: yes
    • Lowenthal: yes
    • Pellerin: yes
    • Berman: yes
    • Irwin: yes
    • Alanis: yes
    • Macedo: no
    • Chen: other
    • Hadwick: other
    • Flora: other

  • Do pass.

    2025-05-14 · pass · 11-4

    Member-level votes (15)
    • Fong: yes
    • Pacheco: yes
    • Pellerin: yes
    • Mark González: yes
    • Hart: yes
    • Calderon: yes
    • Solache: yes
    • Caloza: yes
    • Elhawary: yes
    • Wicks: yes
    • Arambula: yes
    • Sanchez: no
    • Ta: no
    • Tangipa: no
    • Dixon: no

  • AB 260 Aguiar-Curry Assembly Third Reading

    2025-05-19 · pass · 61-11

    Member-level votes (79)
    • Solache: yes
    • Zbur: yes
    • Fong: yes
    • Kalra: yes
    • Michelle Rodriguez: yes
    • Ransom: yes
    • Rivas: yes
    • Ramos: yes
    • Pellerin: yes
    • Muratsuchi: yes
    • Wilson: yes
    • Ortega: yes
    • Schultz: yes
    • Soria: yes
    • Boerner: yes
    • Wicks: yes
    • Sharp-Collins: yes
    • Haney: yes
    • Gabriel: yes
    • Nguyen: yes
    • Pacheco: yes
    • Harabedian: yes
    • Wallis: yes
    • Bennett: yes
    • Bonta: yes
    • Addis: yes
    • Krell: yes
    • Arambula: yes
    • Ward: yes
    • Mark González: yes
    • Quirk-Silva: yes
    • Lowenthal: yes
    • Celeste Rodriguez: yes
    • Ahrens: yes
    • Jackson: yes
    • Bauer-Kahan: yes
    • Hart: yes
    • Valencia: yes
    • Berman: yes
    • Bains: yes
    • Garcia: yes
    • Aguiar-Curry: yes
    • Alvarez: yes
    • Connolly: yes
    • Gipson: yes
    • Stefani: yes
    • Bryan: yes
    • Schiavo: yes
    • Rogers: yes
    • Caloza: yes
    • Blanca Rubio: yes
    • McKinnor: yes
    • Elhawary: yes
    • Carrillo: yes
    • Patel: yes
    • Alanis: yes
    • Calderon: yes
    • Irwin: yes
    • Lee: yes
    • Petrie-Norris: yes
    • Ávila Farías: yes
    • DeMaio: no
    • Ellis: no
    • Patterson: no
    • Castillo: no
    • Ta: no
    • Hadwick: no
    • Gallagher: no
    • Macedo: no
    • Lackey: no
    • Sanchez: no
    • Tangipa: no
    • Chen: other
    • Papan: other
    • Dixon: other
    • Flora: other
    • Davies: other
    • Hoover: other
    • Jeff Gonzalez: other

  • Do pass as amended, but first amend, and re-refer to the Committee on [Business, Professions and Economic Development]

    2025-06-11 · pass · 6-1

    Member-level votes (11)
    • Limón: yes
    • Richardson: yes
    • Wiener: yes
    • Menjivar: yes
    • Padilla: yes
    • Durazo: yes
    • Grove: no
    • Weber Pierson: other
    • Gonzalez: other
    • Valladares: other
    • Rubio: other

  • Do pass, but first be re-referred to the Committee on [Appropriations]

    2025-06-23 · pass · 8-2

    Member-level votes (11)
    • Menjivar: yes
    • Archuleta: yes
    • Weber Pierson: yes
    • Ashby: yes
    • Umberg: yes
    • Grayson: yes
    • Smallwood-Cuevas: yes
    • Arreguín: yes
    • Strickland: no
    • Choi: no
    • Niello: other

  • Placed on suspense file

    2025-07-07 · pass · 6-0

    Member-level votes (7)
    • Cabaldon: yes
    • Richardson: yes
    • Seyarto: yes
    • Caballero: yes
    • Grayson: yes
    • Wahab: yes
    • Dahle: other

  • Do pass

    2025-08-29 · pass · 5-2

    Member-level votes (7)
    • Richardson: yes
    • Grayson: yes
    • Wahab: yes
    • Caballero: yes
    • Cabaldon: yes
    • Dahle: no
    • Seyarto: no

  • 3rd Reading AB260 Aguiar-Curry et al. By Limón Urgency Clause

    2025-09-09 · pass · 30-8

    Member-level votes (40)
    • Richardson: yes
    • Menjivar: yes
    • Cortese: yes
    • Weber Pierson: yes
    • McNerney: yes
    • Stern: yes
    • Smallwood-Cuevas: yes
    • Becker: yes
    • McGuire: yes
    • Cervantes: yes
    • Hurtado: yes
    • Cabaldon: yes
    • Rubio: yes
    • Durazo: yes
    • Laird: yes
    • Padilla: yes
    • Limón: yes
    • Pérez: yes
    • Reyes: yes
    • Archuleta: yes
    • Wiener: yes
    • Ashby: yes
    • Arreguín: yes
    • Grayson: yes
    • Allen: yes
    • Gonzalez: yes
    • Caballero: yes
    • Wahab: yes
    • Umberg: yes
    • Blakespear: yes
    • Ochoa Bogh: no
    • Dahle: no
    • Grove: no
    • Jones: no
    • Seyarto: no
    • Strickland: no
    • Choi: no
    • Alvarado-Gil: no
    • Niello: other
    • Valladares: other

  • AB 260 Aguiar-Curry Concurrence - Urgency Added

    2025-09-11 · pass · 61-12

    Member-level votes (80)
    • Ahrens: yes
    • Mark González: yes
    • Quirk-Silva: yes
    • Gipson: yes
    • Rogers: yes
    • Addis: yes
    • Ward: yes
    • Haney: yes
    • Hart: yes
    • Fong: yes
    • Elhawary: yes
    • Calderon: yes
    • Wilson: yes
    • Carrillo: yes
    • Bains: yes
    • Ransom: yes
    • Soria: yes
    • Michelle Rodriguez: yes
    • Berman: yes
    • Valencia: yes
    • Wicks: yes
    • Celeste Rodriguez: yes
    • Arambula: yes
    • Connolly: yes
    • Schultz: yes
    • Bauer-Kahan: yes
    • Bennett: yes
    • Papan: yes
    • Schiavo: yes
    • Bonta: yes
    • Ávila Farías: yes
    • Aguiar-Curry: yes
    • Pacheco: yes
    • Boerner: yes
    • Alvarez: yes
    • Lee: yes
    • Wallis: yes
    • Stefani: yes
    • Caloza: yes
    • Sharp-Collins: yes
    • Nguyen: yes
    • Ortega: yes
    • Solache: yes
    • Lowenthal: yes
    • Blanca Rubio: yes
    • Jackson: yes
    • Bryan: yes
    • Petrie-Norris: yes
    • Harabedian: yes
    • Gabriel: yes
    • Zbur: yes
    • McKinnor: yes
    • Pellerin: yes
    • Muratsuchi: yes
    • Krell: yes
    • Irwin: yes
    • Ramos: yes
    • Patel: yes
    • Kalra: yes
    • Rivas: yes
    • Garcia: yes
    • Johnson: no
    • Hoover: no
    • Hadwick: no
    • Lackey: no
    • Macedo: no
    • Gallagher: no
    • Sanchez: no
    • Ta: no
    • Castillo: no
    • Ellis: no
    • Patterson: no
    • DeMaio: no
    • Dixon: other
    • Tangipa: other
    • Alanis: other
    • Jeff Gonzalez: other
    • Chen: other
    • Davies: other
    • Flora: other

Related bills

No related bills recorded for this bill.

Official source

http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=202520260AB260

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T01:34:27.960412Z

Inspect retained evidence for changes recorded after evidence tracking began:

Source and document changesStatus and relationship changes

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=CA&identifier=AB 260. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.
  • Some documents have no extracted text yet, so version comparison may be limited.

See the methodology page for data sources and limitations.